CMPX compared with UPB: revenue, margins and what each company keeps, and the suppliers and customers both name

CMPXCompass Therapeutics, Inc.

Mkt capRevenueRevenue

UPBUpstream Bio, Inc.

Mkt capRevenueRevenue

Compare

CMPXCompass Therapeutics, Inc.

UPBUpstream Bio, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

CMPX

0 of 3at or beyond implied

Reportimpliedrealized× implied

Q2 FY26—▲+5.29%—

May 5 '26±16.1%▲+0.52%×0.03

Q1 FY26±52.0%▼−2.81%×0.05

Jan 6 '26±33.6%▼−1.60%×0.05

UPB

1 of 3at or beyond implied

Reportimpliedrealized× implied

Q2 FY26—▼−4.70%—

May 13 '26±10.6%▲+4.58%×0.43

= impliedCMPX realized, solidUPB realized, hatchedOne scale, both sides: full bar = 53%× = |realized| ÷ impliedSource: market data

Q1 FY26

±38.9%

▲+3.38%

×0.09

Feb 11 '26±32.0%▼−47.18%×1.48

CMPXCompass Therapeutics, Inc.

0.79▲+3.85%· post 0.79

Mkt cap$141.6MRevenue$850,000Q2 FY24Revenue—

UPBUpstream Bio, Inc.

3.41▲+4.28%· post 3.40

ClosedOct 30 '26

Mkt cap$186.1MRevenue$773,000Q2 FY26Revenue$3MFY25

Compare

ClosedOct 30 '26

CMPXCompass Therapeutics, Inc.

UPBUpstream Bio, Inc.

0.79▲+3.85%post 0.79

Price

3.41▲+4.28%post 3.40

$141.6M

Mkt cap

$186.1M

Q2 FY24$850,000

Revenue

$773,000Q2 FY26

—

Revenue

$3MFY25

CMPX0.79▲+3.85%vsUPB3.41▲+4.28%ClosedOct 30 '26